Skip to main content
Adastra Holdings logo

Adastra Holdings — Investor Relations & Filings

Ticker · XTRX ISIN · CA00654D2095 LEI · 549300SKMLMH3FJ3AF32 CSE Manufacturing
Filings indexed 489 across all filing types
Latest filing 2023-03-20 Regulatory Filings
Country CA Canada
Listing CSE XTRX

About Adastra Holdings

https://adastraholdings.ca/

Adastra Holdings is a manufacturer and supplier of ethnobotanical and cannabis products for the lawful adult-use and medical markets. The company specializes in the extraction and processing of cannabis, offering a portfolio that includes concentrates, vape pens, wax, resin, and infused pre-rolls. Adastra manufactures products for its proprietary brands, such as Phyto Extractions and Endgame Extracts, and provides co-manufacturing services for partners. A core operational advantage is the co-location of Adastra Labs with Chemia Analytics, an in-house licensed analytical testing and consulting laboratory. This integrated facility ensures rigorous quality control, compliance, and efficient product development, emphasizing a scientific and refined approach to extraction methodologies.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a 'Non-Issuer Form of Submission to Jurisdiction and Appointment of Agent for Service of Process' related to securities distribution under a prospectus dated March 20, 2023. It is a legal filing appointing an agent for service of process and submitting to jurisdiction for legal proceedings related to securities distribution. There are no financial statements, management discussion, earnings data, or report publication announcements. The document is primarily a legal procedural filing related to securities and jurisdiction, not a financial report or announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory and compliance filings that do not fit other specific categories.
2023-03-20 English
News release - English.pdf
Regulatory Filings
2023-03-16 English
News release - English.pdf
Legal Proceedings Report Classification · 100% confidence The document is a press release announcing that Adastra Holdings Ltd. has been served with a civil lawsuit alleging misleading statements in a previous press release. It discusses the company's intention to defend the lawsuit and provides background information about the company. There are no financial statements, no regulatory certifications, no voting results, no management changes, no capital or financing updates, and no earnings or annual report content. The document is primarily a legal proceedings update regarding a class action lawsuit. Therefore, the most appropriate classification is Legal Proceedings Report (LTR). The document length is 3770 characters, which is sufficient for a substantive announcement rather than a brief notice or report publication announcement.
2023-03-15 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' which is a regulatory filing used in Canadian securities regulation to disclose material changes in a company. The content describes a material change regarding the company's Controlled Substances Licence and related activities. It references a news release filed on SEDAR and provides detailed information about the change. The document length is 2367 characters, which is relatively short but contains substantive disclosure about a material change rather than just an announcement of a report. This fits the category of Regulatory Filings (RNS) as it is a regulatory disclosure that does not fit into other specific categories like Annual Report or Earnings Release. It is not a full financial report, nor a management or audit report, but a material change report under National Instrument 51-102, which is a regulatory filing.
2023-03-04 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release clarifying and retracting certain disclosures related to the company's receipt of a Health Canada approval for an amendment to its Controlled Substances Licence. It contains forward-looking statements and company background information but does not include any financial data, financial statements, or detailed report content. It is not an annual report, interim report, earnings release, or any detailed financial or governance report. The document is a regulatory announcement about a corporate update and retraction of prior statements, typical of a Regulatory Filing (RNS). The document length is 6437 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-03-03 English
Material change report - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis for the Nine Months Ended December 31, 2022' and contains detailed discussion of financial position, operational results, forward-looking statements, company overview, project updates, and management changes. It references unaudited condensed consolidated interim financial statements for the nine months ended December 31, 2022, indicating it is a comprehensive financial report for a period shorter than a full fiscal year. The length is about 15,000 characters, which is consistent with a substantive report rather than a brief announcement. The content aligns with the definition of an Interim / Quarterly Report (IR), as it includes actual financial data and analysis for a partial fiscal year period. Therefore, the correct classification is IR with high confidence. 9M 2023
2023-02-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.